Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Light-Measuring tool may improve cancer treatment during surgery

NCT ID NCT03678350

First seen Apr 02, 2026 · Last updated Jun 07, 2026 · Updated 11 times

Summary

This early-phase study tested a light-measuring system used during photodynamic therapy (PDT) for people with malignant mesothelioma, non-small cell lung cancer, or other chest cancers that have spread to the lining of the lungs. Nine participants received a light-activated drug called porfimer sodium during surgery, and doctors used the system to track how much laser light reached the tumor. The main goal was to check safety and see if better light measurement could help guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Roswell Park Cancer Institute

    Buffalo, New York, 14263, United States

Conditions

The condition(s) this trial relates to.

Mesothelioma, Malignant non-small cell lung carcinoma pleural disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.